Analysen von Eliana Merle

11.03.25 BioNTech (ADRs) Neutral UBS AG
02.10.24 BioNTech (ADRs) Neutral UBS AG
18.09.24 BioNTech (ADRs) Neutral UBS AG
10.05.24 BioNTech (ADRs) Neutral UBS AG
20.03.24 BioNTech (ADRs) Neutral UBS AG
09.01.24 BioNTech (ADRs) Neutral UBS AG
14.12.23 BioNTech (ADRs) Neutral UBS AG
28.11.23 BioNTech (ADRs) Neutral UBS AG
02.11.23 Moderna Buy UBS AG
23.10.23 Moderna Buy UBS AG
16.10.23 BioNTech (ADRs) Neutral UBS AG
06.06.23 BioNTech (ADRs) Neutral UBS AG
01.02.23 BioNTech (ADRs) Neutral UBS AG
19.01.23 CureVac Buy UBS AG
15.11.22 BioNTech (ADRs) Neutral UBS AG
30.06.22 BioNTech (ADRs) Neutral UBS AG
23.09.21 BioNTech (ADRs) Neutral UBS AG